Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

North America Extra Corporeal Membrane Oxygenation (Ecmo) System Market Forecast 2019-2028

Published by Inkwood Research Product code 953131
Published Content info 114 Pages
Delivery time: 2-3 business days
Price
Back to Top
North America Extra Corporeal Membrane Oxygenation (Ecmo) System Market Forecast 2019-2028
Published: August 10, 2020 Content info: 114 Pages
Description

KEY FINDINGS

The North America extra corporeal membrane oxygenation (ECMO) system market is projected to register a CAGR of 4.78% during the projected period, 2019-2028. The high prevalence of respiratory diseases is the key factor influencing the growth of the market.

MARKET INSIGHTS

The North America extra corporeal membrane oxygenation (ECMO) system market growth analysis involves the evaluation of the United States and Canada. One of the major public health concerns in Canada is asthma. It affects the quality of life, productivity, psychological wellbeing, etc. of the population. According to the Canada 2019 annual asthma survey report, more than 3 million individuals had asthma in 2019. ECMO (extra corporeal membrane oxygenation) can supply adequate gas exchange during acute respiratory failure. Hence, the market is slated to grow steadily in the coming years. According to the National Clinical Trials Registry (NCT), the researchers from British Columbia are actively putting efforts to triple the survival rate of cardiac arrests. This is being done through the implementation of extracorporeal membrane oxygenation (ECMO)-CPR treatment. It has considerably reduced deaths in transplant waitlist patients. This has propelled the number of successful transplantations in Canada. Clinical professionals recognize ECMO as an efficient therapy. This, coupled with initiatives to increase acceptance, is set to influence the growth of the market in Canada.

COMPETITIVE INSIGHTS

Some of the major companies operating in the market include, Medtronic Plc, Microport Scientific Corporation Nipro Corporation, Spectrum Medical, Origen Biomedical Inc, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 33018

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. MARKET DEFINITION
  • 3.2. KEY DRIVERS
    • 3.2.1. INCREASED USAGE OF ECMO TECHNOLOGY
    • 3.2.2. TECHNOLOGICAL ADVANCEMENT
    • 3.2.3. GROWING BURDEN OF CHRONIC DISORDERS
  • 3.3. KEY RESTRAINTS
    • 3.3.1. LACK OF SPECIALIZED EXPERTISE
    • 3.3.2. HIGH COST OF ECMO SYSTEM
    • 3.3.3. SIDE EFFECTS RELATED TO THE ECMO SYSTEM
    • 3.3.4. PRESENCE OF CONVENTIONAL TECHNIQUES

4. KEY ANALYTICS

  • 4.1. PORTER'S FIVE FORCE ANALYSIS
    • 4.1.1. THREAT OF NEW ENTRY
    • 4.1.2. THREAT OF SUBSTITUTION
    • 4.1.3. BUYER'S POWER
    • 4.1.4. SUPPLIER'S POWER
    • 4.1.5. COMPETITIVE RIVALRY
  • 4.2. IMPACT OF COVID-19 ON ECMO SYSTEM MARKET
  • 4.3. OPPORTUNITY MATRIX
  • 4.4. VENDOR LANDSCAPE
  • 4.5. KEY INVESTMENT INSIGHTS

5. MARKET BY MODALITY

  • 5.1. VENO-VENOUS
  • 5.2. VENO-ARTERIAL
  • 5.3. OTHER MODALITIES

6. MARKET BY APPLICATION

  • 6.1. RESPIRATORY
  • 6.2. CARDIAC
  • 6.3. EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR)

7. GEOGRAPHICAL ANALYSIS

  • 7.1. NORTH AMERICA
    • 7.1.1. THE UNITED STATES
    • 7.1.2. CANADA

8. COMPANY PROFILES

  • 8.1. ABBOTT LABORATORIES
  • 8.2. ALUNG TECHNOLOGIES INC.
  • 8.3. ELSIUS BIOMEDICAL INC
  • 8.4. EUROSETS
  • 8.5. GETINGE AB
  • 8.6. LIVANOVA PLC
  • 8.7. MEDTRONIC PLC
  • 8.8. MICROPORT SCIENTIFIC CORPORATION
  • 8.9. NIPRO CORPORATION
  • 8.10. ORIGEN BIOMEDICAL INC
  • 8.11. SPECTRUM MEDICAL
  • 8.12. TERUMO MEDICAL CORPORATION
  • 8.13. XENIOS AG (FRESENIUS SE & CO KGAA)

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM
  • TABLE 2: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY MODALITY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 3: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY MODALITY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 4: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 5: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 6: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 7: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1: LIST OF CHRONIC DISEASES
  • FIGURE 2: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: KEY INVESTMENT INSIGHTS
  • FIGURE 6: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY MODALITY, IN 2019
  • FIGURE 7: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY VENO-VENOUS, 2019-2028 (IN $ MILLION)
  • FIGURE 8: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY VENO-ARTERIAL, 2019-2028 (IN $ MILLION)
  • FIGURE 9: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY OTHER MODALITIES, 2019-2028 (IN $ MILLION)
  • FIGURE 10: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY APPLICATION, IN 2019
  • FIGURE 11: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY RESPIRATORY, 2019-2028 (IN $ MILLION)
  • FIGURE 12: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY CARDIAC, 2019-2028 (IN $ MILLION)
  • FIGURE 13: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR), 2019-2028 (IN $ MILLION)
  • FIGURE 14: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 15: THE UNITED STATES EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 16: CANADA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
Back to Top